切换至 "中华医学电子期刊资源库"

中华神经创伤外科电子杂志 ›› 2020, Vol. 06 ›› Issue (01) : 39 -43. doi: 10.3877/cma.j.issn.2095-9141.2020.01.010

所属专题: 文献

基础研究

阻断NHE1抑制人胶质母细胞瘤细胞增殖和侵袭的研究
李玉辉1, 赵喜庆1, 陈思1, 刘岩2, 刘艳坤3, 李玉凤3,()   
  1. 1. 063001 唐山市人民医院神经外科
    2. 063210 唐山,华北理工大学生命科学院生物工程系
    3. 063001 唐山市人民医院肿瘤研究所
  • 收稿日期:2019-12-12 出版日期:2020-02-15
  • 通信作者: 李玉凤
  • 基金资助:
    唐山市科技创新团队培养计划项目基金(18130203B)

Blockade of NHE1 inhibits the proliferation and invasion of human glioblastoma

Yuhui Li1, Xiqing Zhao1, Si Chen1, Yan Liu2, Yankun Liu3, Yufeng Li3,()   

  1. 1. Department of Neurosurgery, Tangshan People’s Hospital, Tangshan 063001, China
    2. Department of Bioengineering, College of Life Science, North China University of Science and Technology, Tangshan 063210, China
    3. Cancer Institute, Tangshan People’s Hospital, Tangshan 063001, China
  • Received:2019-12-12 Published:2020-02-15
  • Corresponding author: Yufeng Li
  • About author:
    Corresponding author: Li Yufeng, Email:
引用本文:

李玉辉, 赵喜庆, 陈思, 刘岩, 刘艳坤, 李玉凤. 阻断NHE1抑制人胶质母细胞瘤细胞增殖和侵袭的研究[J/OL]. 中华神经创伤外科电子杂志, 2020, 06(01): 39-43.

Yuhui Li, Xiqing Zhao, Si Chen, Yan Liu, Yankun Liu, Yufeng Li. Blockade of NHE1 inhibits the proliferation and invasion of human glioblastoma[J/OL]. Chinese Journal of Neurotraumatic Surgery(Electronic Edition), 2020, 06(01): 39-43.

目的

分析Na+/H+交换蛋白1(NHE1)抑制剂对癌基因BRAF野生型(BRAFWT)和激活型BRAFV600E突变的胶质母细胞瘤(GBM)细胞生长和侵袭能力的影响。

方法

NHE1抑制剂Cariporide分别处理U251(BRAFWT)和AM38(BRAFV600E)GBM细胞系,乙酰甲酯化的2’,7’-双(2-羧乙基)-5(6)-羧荧光素荧光探针处理细胞并采用紫外分光光度计检测细胞在440 nm与490 nm的荧光强度,计算荧光强度比值以反映NHE1的活性,MTT法检测细胞增殖活性,基质胶-Transwell实验检测细胞侵袭能力。

结果

AM38细胞的NHE1活性、增殖和侵袭能力均显著高于U251细胞,差异均有统计学意义(P=0.006、0.010、0.047);Cariporide处理的U251和AM38细胞的NHE1活性、增殖和侵袭能力均显著低于溶剂二甲基亚砜处理的U251和AM38细胞,差异均有统计学意义(U251:P=0.012、0.023、0.044;AM38:P=0.006、0.001、0.038)。

结论

采用Cariporide阻断NHE1活性可有效抑制BRAFWT和BRAFV600E突变型GBM细胞的增殖和侵袭。

Objective

To analyze the effection of Na+/H+ exchanger 1(NHE1) on proliferation and invasion abilities of oncogene BRAF wild type(BRAFWT) and BRAFV600E mutation type glioblastoma (GBM) cells.

Methods

The U251 (BRAFWT) and AM38 (BRAFV600E) GBM cells were treated with NHE1 inhibitor Cariporide, respectively. The cells were treated with acetoxymethyl ester of 2’,7’-Bis (2-carboxyethyl)-5(6)-carboxyfluorescein fluorescent probe and the fluorescence intensities at 440 nm and 490 nm were detected by ultraviolet spectrophotometer. The fluorescence intensity ratio was calculated to reflect NHE1 activity. The proliferative activity was detected by MTT and the invasion ability was detected by matrigel-Transwell assay.

Results

The NHE1 activity, proliferation and invasion abilities of AM38 cells were all significantly higher than those of U251 cells (P=0.006, 0.010, 0.047, respectively). The NHE1 activity, proliferation and invasion abilities of both Cariporide-treated U251 and Cariporide-treated AM38 cells were all markedly decreased compared with those of DMSO-treated U251 and DMSO-treated AM38 cells, respectively (U251: P=0.012, 0.023, 0.044, respectively; AM38: P=0.006, 0.001, 0.038, respectively).

Conclusion

Cariporide could effectively inhibit the proliferation and invasion abilities of BRAFWT and BRAFV600E mutation type GBM cells.

图1 BCECF-AM荧光探针分析Cariporide对U251细胞和AM38细胞内NHE1活性的影响
图2 MTT法分析Cariporide对U251细胞和AM38细胞生长活性的影响
图3 基质胶-Transwell实验分析Cariporide对U251细胞和AM38细胞侵袭能力的影响
[8]
Neri D,Supuran CT. Interfering with pH regulation in tumours as a therapeutic strategy[J]. Nat Rev Drug Discov, 2011, 10(10): 767-777.
[9]
Brisson L,Reshkin SJ,Goré J, et al. pH regulators in invadosomal functioning: proton delivery for matrix tasting[J]. Eur J Cell Biol, 2012, 91(11-12): 847-860.
[10]
Rich IN,Worthington-White D,Garden OA, et al. Apoptosis of leukemic cells accompanies reduction in intracellular pH after targeted inhibition of the Na(+)/H(+) exchanger[J]. Blood, 2000, 95(4): 1427-1434.
[11]
Amith SR,Fliegel L. Regulation of the Na+/H+ exchanger (NHE1) in breast cancer metastasis[J]. Cancer Res, 2013, 73(4): 1259-1264.
[12]
Cong D,Zhu W,Shi Y, et al. Upregulation of NHE1 protein expression enables glioblastoma cells to escape TMZ-mediated toxicity via increased H+ extrusion, cell migration and survival[J]. Carcinogenesis, 2014, 35(9): 2014-2024.
[13]
Karumanchi SA,Jiang L,Knebelmann B, et al. VHL tumor suppressor regulates Cl-/HCO3-exchange and Na+/H+ exchange activities in renal carcinoma cells[J]. Physiol Genomics, 2001, 5(3): 119-128.
[14]
Kislin KL,McDonough WS,Eschbacher JM, et al. NHERF-1: modulator of glioblastoma cell migration and invasion[J]. Neoplasia, 2009, 11(4): 377-387.
[15]
Ludwig FT,Schwab A,Stock C. The Na+/H+-exchanger (NHE1) generates pH nanodomains at focal adhesions[J]. Cell Physiol, 2013, 228(6): 1351-1358.
[16]
Wang J,Xu H,Wang Q, et al. CIAPIN1 targets Na+/H+ exchanger 1 to mediate MDA-MB-231 cells’ metastasis through regulation of MMPs via ERK1/2 signaling pathway[J]. Exp Cell Res, 2015, 333(1): 60-72.
[17]
石文建,刘志广,张欢,等.突变型Braf通过NHE1促进胶质母细胞瘤的侵袭[J].基因组学与应用生物学, 2018, 37(3): 1094-1097.
[18]
石文健,赵喜庆,张欢,等.沉默NHE1抑制胶质母细胞瘤细胞的迁移和侵袭能力[J].基因组学与应用生物学, 2017, 36(12): 4984-4991.
[19]
Harguindey S,Arranz JL,Polo Orozco JD, et al. Cariporide and other new and powerful NHE1 inhibitors as potentially selective anticancer drugs--an integral molecular/biochemical/metabolic/clinical approach after one hundred years of cancer research[J]. J Transl Med, 2013, 11: 282.
[20]
Lin Y,Chang G,Wang J, et al. NHE1 mediates MDA-MB-231 cells invasion through the regulation of MT1-MMP[J]. Exp Cell Res, 2011, 317(14): 2031-2040.
[21]
Di Sario A,Bendia E,Omenetti A, et al. Selective inhibition of ion transport mechanisms regulating intracellular pH reduces proliferation and induces apoptosis in cholangiocarcinoma cells[J]. Dig Liver Dis, 2007, 9(1): 60-69.
[22]
Lee YJ,Base JH,Kim SA, et al. Cariporide enhances the DNA damage and apoptosis in acid-tolerable malignant mesothelioma H-2452 cells[J]. Mol Cells, 2017, 40(8): 567-576.
[23]
Robinson GW,Orr BA,Gajjar A. Complete clinical regression of a BRAF V600E-mutant pediatric glioblastoma multiforme after BRAF inhibitor therapy[J]. BMC Cancer, 2014, 14: 258.
[24]
Upadhyaya SA,Robinson GW,Harreld JH, et al. Marked functional recovery and imaging response of refractory optic pathway glioma to BRAFV600E inhibitor therapy: a report of two cases[J]. Childs Nerv Syst, 2018, 34(4): 605-610.
[25]
Yao TW,Zhang J,Prados M, et al. EGFR blockade prevents glioma escape from BRAFV600E targeted therapy[J]. Oncotarget, 2015, 6(26): 21993-22005.
[26]
Zhang J,Yao TW,Hashizume R, et al. Combined BRAFV600E and MEK blockade for BRAFV600E-mutant gliomas[J]. Neurooncol, 2017, 131(3): 495-505.
[27]
Guan XD,Hasan MN,Begum G, et al. Blockade of Na/H exchanger stimulates glioma tumor immunogenicity and enhances combinatorial TMZ and anti-PD-1 therapy[J]. Cell Death Dis, 2018, 9(10): 1010.
[28]
Brown NF,Carter T,Kitchen N, et al. Dabrafenib and trametinib in BRAFV600E mutated glioma[J]. CNS Oncol, 2017, 6(4): 291-296.
[1]
Louis DN,Perry A,Reifenberger G, et al. The 2016 world health organization classification of tumors of the central nervous system: a summary[J]. Acta Neuropathol, 2016, 131(6): 803-820.
[2]
Liau LM,Ashkan K,Tran DD, et al. First results on survival from a large phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma[J]. J Transl Med, 2018, 16(1): 142.
[3]
Davies H,Bignell GR,Cox C, et al. Mutations of the BRAF gene in human cancer[J]. Nature, 2002, 417(6892): 949-954.
[4]
Schindler G,Capper D,Meyer J, et al. Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytoma[J]. Acta Neuropathol, 2011, 121(3): 397-405.
[5]
Kleinschmidt-DeMasters BK,Aisner DL,Birks DK, et al. Epithelioid GBMs show a high percentage of BRAF V600E mutation[J]. Am J Surg Pathol, 2013, 37(5): 685-698.
[6]
Guan X,Luo L,Begum G, et al. Elevated Na/H exchanger 1 (SLC9A1) emerges as a marker for tumorigenesis and prognosis in gliomas[J]. Exp Clin Cancer Res, 2018, 37(1): 255.
[7]
Cardone RA,Casavola V,Reshkin SJ. The role of disturbed pH dynamics and the Na+/H+ exchanger in metastasis[J]. Nat Rev Cancer, 2005, 5(10): 786-795.
No related articles found!
阅读次数
全文


摘要